🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested
The primary objectives of this study are to evaluate the antiretroviral act...
Status
Completed
Location
Multiple Locations
Start Date
2016-01-14
Trial ID
NCT02629822
Treatments Being Tested
Transgender men (trans men; assigned female sex at birth but identify as ma...
Status
Completed
Location
Infectious Diseases Institute Kasangati
Start Date
2021-09-16
Trial ID
NCT04867798
Treatments Being Tested
To evaluate the therapeutic equivalence between the two arms of treatment i...
Status
Completed
Location
Institute of Infections and Tropical Diseases University of Brescia
Start Date
2004-04
Trial ID
NCT00318123
Treatments Being Tested
The primary objective of this study in antiretroviral (ARV)-naïve Human imm...
Status
Terminated
Location
Multiple Locations
Start Date
2012-07-31
Trial ID
NCT01620944
Treatments Being Tested
Dolutegravir (DTG) and lamivudine (3TC) are indicated in combination with o...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-05
Trial ID
NCT02738931
This study will compare safety, efficacy, and tolerability of a two drug re...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-07-18
Trial ID
NCT02831764
Treatments Being Tested
First-line antiretroviral regimens are highly efficacious and generally wel...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-05-06
Trial ID
NCT03682848
Treatments Being Tested
Dolutegravir is a potent integrase strand transfer inhibitor. Abacavir/dolu...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-06-06
Trial ID
NCT03016533
The main objective of this observational study is to assess the adherence o...
Status
Completed
Location
Service de maladies infectieuses et tropicales du CHU de Montpellier
Start Date
2023-06-08
Trial ID
NCT05761509
Treatments Being Tested